Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers
2006年10月12日 更新者:Ethicon, Inc.
A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers
This is a randomized (1:1), prospective, open label, multicenter, comparative study to be examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on diabetic foot ulcers.
研究概览
研究类型
介入性
注册
48
阶段
- 第四阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Florida
-
Ft. Lauderdale、Florida、美国
- Wound Care Center
-
South Miami、Florida、美国
- Foot and Ankle Institute of South Florida
-
-
Pennsylvania
-
Warren、Pennsylvania、美国、16365
- Penn North Centers for Advanced Wound Care
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不适用
有资格学习的性别
全部
描述
Inclusion Criteria:
- 18 years of age or older.
- Ambulatory (i.e. walking is the primary method of mobilization. Crutches, walker, walking frame or other ambulation aids are permitted).
- Diagnosed Type 2 diabetic (i.e. not juvenile onset).
- Have a DFU on the plantar surface of either foot.
- Have a DFU of >4 wks but <6 months duration.
- Willing and capable of cooperating to the extent and degree required by the study protocol
Exclusion Criteria:
- Be < 1cm2 or >10cm2 in area, by planimetry.
- Demonstrate overt signs of infection.
- Be located on the dorsal, lateral, or posterior heel area of the foot (Change 2, Amendment 1).
- Have visible exposed bone or tendon.
- Have an adjacent thermal injury or wound of an etiology other than diabetes.
- Be within 5 cm of any other wound, regardless of etiology.
- Have received enzymatic debriding agents in the past 7 days.
- Have received topical antibiotic therapy in the past 7 days.
- Be less than 1 cm2 or exceed 10cm2 in area by planimetry, after debridement.
- Have exposed bone or tendon, after debridement
The study subject MUST NOT:
- Have received previous treatment for the study ulcer by this Investigator.
- Have more than 3 full thickness ulcers, in total.
- Be pregnant or nursing an infant
- Have a concurrent illness or condition which may interfere with wound healing, such as carcinoma, vasculitis, immune system disorders or connective tissue disorder.
- Be a known alcohol or drug abuser.
- Have received systemic corticosteroids, immunosuppressive or chemotherapeutic agents in the past 30 days.
- Have received radiotherapy, which includes the lower extremity, at any time.
- Have a marked Charcot foot or claw foot deformity which would limit the ability of the subject to wear or be compliant with the wearing of the standardized off-loading device used in this study.
- Have received an investigational drug or device in the past 30 days.
- Have a known hypersensitivity to bovine collagen, oxidized regenerated cellulose (ORC) or silver.
- Be unwilling or unable to be fitted or compliant with the wearing of an ulcer off-loading device.
- Known to be non-compliant or unlikely to complete the study.
- Have ABPI < 0.7, OR, if ABPI >1.0 and toe pressure >0.6.
- Have serum Creatinine > 3 mg/dL25. have Hgb A1C>9%
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
研究衡量的是什么?
主要结果指标
结果测量 |
|---|
|
Clinical effectiveness of CAM in DFU by comparing the reduction in wound area between 2 treatment groups.
|
次要结果测量
结果测量 |
|---|
|
生活质量
|
|
Rate of wound closure
|
|
Ease of use and adverse events
|
|
Wound odor
|
|
Wound characteristics
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2004年7月1日
研究完成
2005年12月1日
研究注册日期
首次提交
2005年10月6日
首先提交符合 QC 标准的
2005年10月6日
首次发布 (估计)
2005年10月10日
研究记录更新
最后更新发布 (估计)
2006年10月13日
上次提交的符合 QC 标准的更新
2006年10月12日
最后验证
2006年10月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.